stockrowOneMedNet Corporation
ONMD Healthcare Health Information Services
OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024.
- Revenue
- +88.4%
- EPS
- −157.1%
- Free cash flow
- +14.1%
- Total debt
- +75.3%
Quarter to June 2026, against a year earlier
Follow ONMD
Alert me
OneMedNet Corporation (ONMD) EV/Sales
As of 5 November 2026, OneMedNet Corporation (ONMD) trades at a EV/Sales of 17.1×. Over the past ten years it has ranged from 0.0× (December 2023) to 337× (October 2025); the current reading is higher than 53% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 36.0× | (42.96%) |
| FY2024 | 63.1× | 595.10% |
| FY2023 | 9.1× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 28.6× | (20.77%) |
| Mar 2026 | 36.1× | 0.31% |
| Dec 2025 | 36.0× | (69.70%) |
| Sep 2025 | 119× | 144.38% |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| HLTHQ Cue Health Inc. compare | −1.1× |
| BEAT HeartBeam, Inc. compare | n/m |
| LFMD LifeMD, Inc. compare | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.7× |
| CCLD CareCloud, Inc. compare | 1.0× |
| DRIO DarioHealth Corp. compare | 2.5× |
| RNLXY Renalytix plc - Sponsored ADR compare | 2.8× |
| BFRG Bullfrog AI Holdings Inc. compare | 6.0× |
| ONMD OneMedNet Corporation | 17.1× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)